Crossmark

The DLC-1 tumor suppressor is involved in regulating immunomodulation of human mesenchymal stromal /stem cells through interacting with the Notch1 protein

Crossref DOI link: https://doi.org/10.1186/s12885-020-07542-5

Published Online: 2020-11-04

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Na, Tao

Zhang, Kehua

Yuan, Bao-Zhu
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (H1609-81172102)

National Key Research and Development Program of China Stem Cell and Translational Research (2016YFA0101501)
License Information

Text and Data Mining valid from 2020-11-04

Version of Record valid from 2020-11-04
More Information

Article History

Received: 14 December 2019

Accepted: 20 October 2020

First Online: 4 November 2020

Ethics approval and consent to participate

: None of the cell lines used in the present study required ethics approval for their use.

: Not relevant.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below